Molecular pathology and cancer biology data suggest that HGF/MET signaling plays a crucial role in the survival, growth, proliferation, metastasis, and drug resistance of osteosarcoma (Coltella et al., 2003; Wang et al., 2012; Kunii et al., 2015). The gene discussed is MET; the disease is osteosarcoma.